Please provide your email address to receive an email when new articles are posted on . The number of antibacterial agents in clinical and preclinical development decreased from 97 to 90. Of these, 40 ...
The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...
In an era where medical advancements are celebrated daily, a silent crisis looms large, threatening to unravel decades of progress in global health. According to the latest World Health Organisation ...
Antimicrobial resistance (AMR) is one of the most urgent public health challenges in 2025. This phenomenon occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve resistance ...
Strategy Leader, Infectious Diseases, Medicines Discovery Catapult, and Director of PACE Antimicrobial resistance (AMR) is not a future problem; it is unfolding now. In 2019, almost five million ...
WHX Labs In Dubai To Gather Global Experts In Antimicrobial Resistance At Inaugural AMR Leaders' Summit. <li /> The World ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the company’s lead candidate at the upcoming Interdisciplinary ...
Company plans to launch multiple direct-from-blood diagnostics over the next 15 months for antimicrobial resistance, pediatric Candida infections, Lyme disease, and Candida auris The Company plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback